Cannapharmarx Inc Quick Ratio (CPMD) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Cannapharmarx Inc   (CPMD)

Cannapharmarx Inc 's Quick Ratio

CPMD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 0 a new company low.

Within Major Pharmaceutical Preparations industry 462 other companies have achieved higher Quick Ratio than Cannapharmarx Inc in second quarter 2026. While total ranking remained the same in the Q2 2026 compared to the first quarter 2026 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents CPMD´s has?
What are CPMD´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CPMD/financial-strength
https://api.csimarket.com/api/v1/companies/CPMD/fundamentals
https://api.csimarket.com/api/v1/companies/CPMD/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
CPMD Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -58.14 %
Y / Y Cash & cash equivalent Change -
Quick Ratio MRQ 0
CPMD's Total Ranking #
Seq. Current Liabilities Change -61.51 %
Seq. Cash & cash equivalent Change -



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 463
Healthcare Sector # 940
Overall Market # 4581


Quick Ratio Statistics
High Average Low
2.53 0.21 0
(Jun 30 2015)   (Dec 31 2023)




Financial Statements
Cannapharmarx Inc 's Current Liabilities $ 12 Millions Visit CPMD's Balance sheet
Cannapharmarx Inc 's Cash & cash equivalent $ 0 Millions Visit CPMD's Balance sheet
Source of CPMD's Sales Visit CPMD's Sales by Geography


Cumulative Cannapharmarx Inc 's Quick Ratio

CPMD's Quick Ratio for the trailling 12 Months

CPMD Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -31.75 %
Y / Y Cash & cash equivalent TTM Growth -
Quick Ratio TTM 0
Total Ranking TTM # 4203
Seq. Current Liabilities TTM Growth -16.93 %
Seq. Cash & cash equivalent TTM Growth -


On the trailing twelve months basis In spite of the year on year decrease in CPMD's Current Liabilities to $12.12 millions, cumulative Quick Ratio